InvestorsHub Logo
Followers 2
Posts 429
Boards Moderated 0
Alias Born 07/13/2016

Re: A deleted message

Wednesday, 06/28/2017 3:57:20 PM

Wednesday, June 28, 2017 3:57:20 PM

Post# of 233513
On my timeline that puts mono commercialization out to late 2019, that assumes the FDA only requires one phase III trial. However, thy may very well require two phase III's and that put commercialization out to late 2020 assuming they require another 48 week test.

Moreover, this would also likely mean they need more cash to get to the finish line and, therefore, more dilution.

Does anyone know if the company thinks they will get by with just one phase III trial?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News